A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

The two main incretins involved in this process are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Currently, there are two approved GLP-1 and one combined ...

Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

Eli Lilly is paying up to $630m for a Phase I MASH candidate from OliX Pharmaceuticals, diversifying its pipeline with an RNA ...

Yet the soaring enthusiasm for so-called glucagon-like peptide-1 receptor ... Read our editorial policy to learn more about our process.

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on developing treatments for liver disease and obesity, has been garnering attention ...

Alcoholism and alcohol use disorder (AUD) are major public health and socioeconomic issues. However, a handful of pharmacotherapeutic agents are available ...